Real-time enrollment status for this ovarian cancer clinical trial
Current Status
Recruiting
Checked: October 21, 2026 at 10:06 PM UTC
| NCT Number | NCT07778498 |
| Recruiting Status | Recruiting |
| Condition | Ovarian Cancer |
| Phase | PHASE1 |
| Target Enrollment | 150 participants |
| Active Locations | 8 sites in the US |
| Sponsor | Phrontline Biopharma |
| Last Updated on CT.gov | October 21, 2026 (22 hours ago) |
As of October 21, 2026: Clinical trial NCT07778498 is currently recruiting participants. This phase1 study for ovarian cancer is actively seeking new participants at 8 locations across the United States. The study is sponsored by Phrontline Biopharma. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07778498 is actively recruiting participants as of October 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 8 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07778498 was last updated 22 hours ago (October 21, 2026). HelloStudys verifies this status automatically.